Medipol Pharmaceutical India Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 1992.

1992 Delhi, Delhi, India Active

Last Updated: December 30, 2025

About Medipol Pharmaceutical India Private Limited

Medipol Pharmaceutical India Private Limited, a active private limited company, was established on 01 May 1992 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231DL1992PTC363074. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹11.00 Cr and a paid-up capital of ₹6.69 Cr.

Formerly known as Kansal Associates Pvt Ltd. It upholds a compliant status. Employing 64 professional, Its leadership includes Yogesh Gupta (Director), Umesh Kumar Gupta (Director), Sanjay Agarwal (Director). Past directors included Jagdish Kumar Gupta, Yogesh Gupta, Aditya Gupta. It holds ₹20.90 Cr open charges and ₹8.27 Cr settled loans. Its latest AGM occurred on 30 December 2024, with the balance sheet filed on 31 March 2024. It is based at 1/2344 Subhash Marg Ram Nagar Shahdara, Delhi, Delhi, 110032.

Company Details

CIN/LLPIN
U24231DL1992PTC363074
Registration Number
363074
Incorporation Date
01 May 1992
Authorized Capital
₹11.00 Cr
Paid-Up Capital
₹6.69 Cr
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 11.00 Cr as on 30-12-2025
Paid Up Capital ₹ 6.69 Cr as on 30-12-2025
Company Age 33 Year, 9 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 20.90 Cr as on 30-12-2025
Satisfied Charges ₹ 8.27 Cr as on 30-12-2025
Revenue Growth **** 24.68% (FY 2024)
Profit Growth **** 348.60% (FY 2024)
Ebitda **** 13.24% (FY 2024)
Net Worth 2.75% (FY 2024)
Total Assets -4.71% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Medipol Pharmaceutical India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Medipol Pharmaceutical India Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Yogesh Gupta	Director	11 Oct 1999	Current
Umesh Kumar Gupta	Director	01 Mar 2004	Current
Sanjay Agarwal	Director	07 Dec 2023	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	06 Oct 2011	Past
Pramod Abcsdd	Director	04 Oct 2024	Past
Pramod Abcsdd	Additional Director	27 Oct 2021	Past
Pramod Abcsdd	Director	01 Dec 2025	Past
Pramod Abcsdd	Director	06 Oct 2011	Past
Pramod Abcsdd	Additional Director	07 Dec 2007	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medipol Pharmaceutical India.

Medipol Pharmaceutical India Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 24.68% increase. The company also saw a substantial improvement in profitability, with a 348.6% increase in profit. The company's net worth moved up by a moderate rise of 2.75%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

24.68%

*******

Revenue from Operations

*******

24.56%

*******

Total Assets

*******

-4.71%

*******

Profit or Loss

*******

348.60%

*******

Net Worth

*******

2.75%

*******

EBITDA

*******

13.24%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medipol Pharmaceutical India?

In 2024, Medipol Pharmaceutical India had a promoter holding of 28.95% and a public holding of 71.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹209,000,000.00

Satisfied Charges

₹82,700,000.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 20.90 Cr

Latest Charge Details

Date	Lender	Amount	Status
24 Jan 2011	Hdfc Bank Limited	₹20.90 Cr	Open
16 Jan 2008	State Bank Of India	₹5.80 Cr	Satisfied
16 Jan 2008	State Bank Of India	₹7.30 M	Satisfied
28 Mar 2005	Bank Of Maharashtra	₹1.40 Cr	Satisfied
28 Mar 2005	Bank Of Maharashtra	₹3.40 M	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Medipol Pharmaceutical India?

Medipol Pharmaceutical India has a workforce of 64 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Medipol Pharmaceutical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medipol Pharmaceutical India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medipol Pharmaceutical India

Recent Activity within the Organization

Annual General Meeting

Medipol Pharmaceutical India Private Limited last Annual general meeting of members was held on 30 Dec 2024 as per latest MCA records. was recorded as a recent event.
30 Dec 2024
Balance Sheet

Progress on Medipol Pharmaceutical India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
31 Mar 2024
Director Appointment

Progress on Sanjay Agarwal was appointed as a Director was appointed as a Director on 07 Dec 2023 & has been associated with this company since 2 years 2 months . was documented.
07 Dec 2023
Charges

Progress on A charge with Hdfc Bank Limited of Rs. 20.90 Cr registered on 24 Jan 2011 with Charge ID 10270993 was modified on 26 Sep 2020. was documented.
26 Sep 2020
Charges

The activity A charge registered on 16 Jan 2008 via Charge ID 10086345 with State Bank Of India was fully satisfied on 07 Apr 2011. was completed.
07 Apr 2011
Charges

The activity A charge registered on 16 Jan 2008 via Charge ID 10086348 with State Bank Of India was fully satisfied on 07 Apr 2011. was completed.
07 Apr 2011

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Medipol Pharmaceutical India Private Limited?

The CIN of Medipol Pharmaceutical India Private Limited is U24231DL1992PTC363074.

Where is Medipol Pharmaceutical India Private Limited headquartered?

Medipol Pharmaceutical India Private Limited is headquartered at 1/2344 Subhash Marg Ram Nagar Shahdara, Delhi, Delhi, 110032.

When was Medipol Pharmaceutical India Private Limited incorporated?

Medipol Pharmaceutical India Private Limited was incorporated on 01 May 1992.

Who are the current directors of Medipol Pharmaceutical India Private Limited?

The current directors of Medipol Pharmaceutical India Private Limited are

What is the primary industry of Medipol Pharmaceutical India Private Limited?

The primary industry of Medipol Pharmaceutical India Private Limited is Manufacturing.

Is Medipol Pharmaceutical India Private Limited a listed company?

Medipol Pharmaceutical India Private Limited is unlisted.

What is the capital structure of Medipol Pharmaceutical India Private Limited?

The authorized capital of Medipol Pharmaceutical India Private Limited is ₹11.00 Cr, and the paid-up capital is ₹6.69 Cr.

What is the compliance status of Medipol Pharmaceutical India Private Limited?

The compliance status of Medipol Pharmaceutical India Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available